Articles by Michelle Hoffman - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Michelle Hoffman

Quality Counts

Pharma companies could benefit from the lessons learned in this fall's financial crisis.
Nov 2, 2008

Pharma companies could benefit from the lessons learned in this fall's financial crisis.

The Past as Prologue

Can previous trends of Democratic and Republican administrations predict industry's future?
Oct 2, 2008

Can previous trends of Democratic and Republican administrations predict industry's future?

Dirty Hands

Are hypersanitation trends a result of scaremongering or a lack of faith in medicine?
Sep 2, 2008

Are hypersanitation trends a result of scaremongering or a lack of faith in medicine?

FDA and Medicare at Odds?

Legislative decisions to increase Medicare's formulary may lead to a fight over drug approvals.
Aug 2, 2008

Legislative decisions to increase Medicare's formulary may lead to a fight over drug approvals.

Contract Vendors, They Are A Changin'

As pharma companies outsource new types of projects, contractors are trying to meet new needs.
Aug 1, 2008

As pharma companies outsource new types of projects, contractors are trying to meet new needs.

Contract Service Providers: The State of the Market

Outsourcing strategies of large pharma companies are changing. The CEO of Patheon talks about his company's plan to meet customers' changing needs.
Aug 1, 2008

Outsourcing strategies of large pharma companies are changing. The CEO of Patheon talks about his company's plan to meet customers' changing needs.

Coming Down the Pike: Protein-Substrate Binding

Drugmakers seeking to block the activity of a protein may have a new strategy at their disposal.
Jul 2, 2008

Drugmakers seeking to block the activity of a protein may have a new strategy at their disposal.

How to Pay for it All?

With no economic relief in sight, industry, like all of us, is grappling with high—and new—costs.
Jul 2, 2008

With no economic relief in sight, industry, like all of us, is grappling with high—and new—costs.

Public Service Versus Self-Service

The good, the bad, and the ugly about direct-to-consumer advertising.
Jun 2, 2008

The good, the bad, and the ugly about direct-to-consumer advertising.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here